Spectre Bio

Spectre Bio is a biotechnology company developing a non-antibiotic prophylactic vaccine for recurrent UTIs, a major unmet medical need and significant driver of antimicrobial resistance.

The company's platform produces programmable, non-replicative bacterial cells that retain a full native antigen profile while being completely inactivated, created through a proprietary process that removes a bacterium's genome while preserving essential cellular machinery.

This approach is designed to break the cycle of recurrent infection without relying on antibiotic treatment.